Kurt W. Briner, Director at PROGENICS PHARMACEUTICALS INC (PGNX), sold 20,000 shares at $8.27 ($165K) on 2011-05-13, disclosed to the SEC on 2011-05-17.
Open-market sale of $165k PGNX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.27 | 15,000 | $124K | 75.2% |
| 2 | $8.19 | 5,000 | $41K | 24.8% |
| Total | $8.25 avg | 20,000 | $165K | 100% |
| Filing → |
| BIOA | BUY | 2016-05-24 | $76K | — | Filing → |
| BIOA | BUY | 2015-08-10 | $240K | — | Filing → |
| BIOA | BUY | 2015-05-08 | $90K | — | Filing → |